DIG
AEON icon

Dauntless Investment Group’s AEON Biopharma AEON Stock Holding History

Dauntless Investment Group’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.98M Buy
12,490,154
+9,962,379
+394% +$8.33M 7.06% 4
2026
Q1 		$2.49M Buy
2,527,775
+395,923
+19% +$443K 1.65% 10
2025
Q4 		$1.32M Buy
2,131,852
+1,006,852
+89% +$941K 1.05% 14
2025
Q3 		$910K Hold
1,125,000
– – 0.57% 29
2025
Q2 		$475K Buy
1,125,000
+100,000
+10% +$57.4K 0.83% 23
2025
Q1 		$594K Buy
+1,025,000
New +$7.3M 0.7% 27

Other funds holding AEON

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dauntless Investment Group's AEON Position: Q2 2026 in Review

Dauntless Investment Group increased its AEON Biopharma (AEON) stake by 394% in Q2 2026, buying an estimated $8.33M and bringing the position to 12,490,154 shares worth $8.98M. The position accounts for 7.06% of the portfolio, ranked #4.

Dauntless Investment Group first reported a position in AEON in Q1 2025 and has held it in 6 quarters since. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Dauntless Investment Group held 12,490,154 shares of AEON Biopharma worth $8.98M as of Q2 2026.
  • Dauntless Investment Group bought 9,962,379 AEON Biopharma shares in Q2 2026, an estimated $8.33M.
  • AEON Biopharma made up 7.06% of Dauntless Investment Group's portfolio in Q2 2026, its #4 holding.
  • Dauntless Investment Group first reported a position in AEON Biopharma in Q1 2025 and has held it in 6 quarters since.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.